CHALLENGES FACED IN TRANSFERRING ECONOMIC EVALUATIONS TO MIDDLE INCOME COUNTRIES

International Journal of Technology Assessment in Health Care
Michael DrummondSachin Kamal-Bahl

Abstract

Decision makers in middle-income countries are using economic evaluations (EEs) in pricing and reimbursement decisions for pharmaceuticals. However, whilst many of these jurisdictions have local submission guidelines and local expertise, the studies themselves often use economic models developed elsewhere and elements of data from countries other than the jurisdiction concerned. The objectives of this study were to describe the current situation and to assess the challenges faced by decision makers in transferring data and analyses from other jurisdictions. Experienced health service researchers in each region conducted an interview survey of representatives of decision making bodies from jurisdictions in Asia, Central and Eastern Europe, and Latin America that had at least 1 year's experience of using EEs. Representatives of the relevant organizations in twelve countries were interviewed. All twelve jurisdictions had developed official guidelines for the conduct of EEs. All but one of the organizations evaluated studies submitted to them, but 9 also conducted studies and 7 commissioned them. Nine of the organizations stated that, in evaluating EEs submitted to them, they had consulted a study performed in a different jurisdict...Continue Reading

References

Nov 20, 2004·BMJ : British Medical Journal·Joanna Coast
Nov 6, 2009·PharmacoEconomics·Federico AugustovskiSebastián García Martí
Nov 11, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Michael DrummondJohan Severens
Jan 12, 2010·International Journal of Technology Assessment in Health Care·Peter J NeumannSean D Sullivan
Jul 30, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Marco BarbieriUNKNOWN ISPOR Good Research Practices Economic Data Transferability Task Force
Jun 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jeroen P JansenJoseph C Cappelleri
Jun 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·David C HoaglinAnnabel Barrett
May 9, 2012·International Journal of Technology Assessment in Health Care·Michael DrummondSean D Sullivan
May 9, 2012·International Journal of Technology Assessment in Health Care·Andres Pichon-RiviereMichael Drummond
Sep 25, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·J Jaime CaroUNKNOWN ISPOR-SMDM Modeling Good Research Practices Task Force
Aug 27, 2013·Journal of Health Politics, Policy and Law·Michael Drummond

❮ Previous
Next ❯

Citations

Jun 5, 2016·Orphanet Journal of Rare Diseases·Tamás ZeleiZoltán Kaló
Oct 19, 2017·Journal of Comparative Effectiveness Research·Antonio Olry de Labry LimaFernanda Lessa
Apr 25, 2017·International Journal of Technology Assessment in Health Care·Bertalan NémethZoltán Kaló
May 19, 2020·Pharmacoepidemiology and Drug Safety·Maribel SalasUlf Bergman
Apr 20, 2020·Value in Health Regional Issues·Ibrahim AlabbadiMuna Alshazili
Dec 20, 2017·Value in Health Regional Issues·Diego RosselliZoltán Kaló
May 21, 2021·Value in Health Regional Issues·Emad AlmomaniZoltán Kaló
Jan 22, 2019·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Finn Børlum KristensenAllan Wailoo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Opinion on Pharmacotherapy
Jennifer A Gillette, Rosanna Tarricone
The Journal of Mental Health Policy and Economics
Christine Godfrey, Steve Parrott
© 2021 Meta ULC. All rights reserved